Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of C5 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of C5 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of C5 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of C5 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of C5 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of C5 mRNA | decreases expression | 20106945
|
D003687 |
Dehydroepiandrosterone |
Dehydroepiandrosterone results in decreased expression of C5 mRNA | decreases expression | 18709148
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of C5 mRNA | decreases expression | 19638242
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [C5 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16116186
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [C5 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 16116186
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [C5 protein results in decreased expression of [IL12A protein binds to IL12B protein]] | affects binding|decreases expression|decreases reaction | 16116186
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [C5 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16116186
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [C5 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 16116186
|
D010656 |
Phenylephrine |
C5 protein affects the susceptibility to Phenylephrine | affects response to substance | 10750764
|
C539676 |
rEV576 protein, tick |
rEV576 protein, tick binds to and results in decreased activity of C5 protein | affects binding|decreases activity | 15699138 17445829
|
C539676 |
rEV576 protein, tick |
rEV576 protein, tick binds to and results in increased stability of and results in decreased activity of C5 protein | affects binding|decreases activity|increases stability | 18536718
|
C539676 |
rEV576 protein, tick |
rEV576 protein, tick binds to and results in decreased activity of C5 protein | affects binding|decreases activity | 17215252
|
C539676 |
rEV576 protein, tick |
rEV576 protein, tick results in decreased activity of C5 protein | decreases activity | 18844789
|
C539676 |
rEV576 protein, tick |
rEV576 protein, tick results in decreased activity of C5 protein | decreases activity | 19194881
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of C5 mRNA | decreases expression | 20106945 15056799
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of C5 mRNA | increases expression | 11489354
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12A mRNA] | decreases expression|decreases reaction | 16116186
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in decreased expression of [IL12A protein binds to IL12B protein]] | affects binding|decreases expression|decreases reaction | 16116186
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12B mRNA] | decreases expression|decreases reaction | 16116186
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in decreased expression of IL23A mRNA] | decreases expression|decreases reaction | 16116186
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.88 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.33 | 19061943 17162532 16434500 19052882 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.33 | 16835633 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
5.84 | 17302879 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.16 | 17460149 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.10 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.63 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.96 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.64 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.64 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.64 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.64 | 20432363 19519916 16779866 19052882 11831363 16878318 18056438 17428255 18978308 17978847 16681979 18785209 18691550 17138121 16830150 19394651 20007298 18506893 17162532 19539802 20524982 16807293 19107877 19171122 19383236 19701751 20512989 18210153 19822196 17173139 16540662 3581430 16698587 20084675 20101231 20935162 21159647 19919837 18494052 19335982 19208518 18393292 18971187 3084413 16569478 17055752 16935385 16288022 20214788 17761372 16502159 18788625 19418558 16328049 20514400 10672840 20727157 18665156 10737359 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.98 | 15728586 11179087 11754973 17124262 16170337 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.98 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.37 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.37 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.37 | 17174075 2727394 7505956 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.49 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.49 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.95 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 15668235 8697196 15340226 12621046 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.14 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.14 | 18551238 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
3.71 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.26 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.09 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.09 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.09 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.09 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.21 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.90 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
7.90 | 21071580 20387270 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.72 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.72 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.36 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 12621046 16120746 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16959395 18606429 16354765 15340226 8697196 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.72 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.72 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.72 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.61 | 18502941 12791704 |
MESH:D007105 |
Immune Complex Diseases |
marker/mechanism |
|
| |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.98 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.98 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.37 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.63 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.63 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.63 | 12371664 |
MESH:C537005 |
Leiner disease |
marker/mechanism |
|
| |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
5.31 | 16972261 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.85 | 18665156 18407596 20032147 19638242 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.47 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.47 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
14.47 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.47 | 21071580 19690152 18648771 19833225 19090486 21047994 2422723 20492335 15175105 18754104 19551842 12771043 19254457 19256749 2862719 19638242 19294768 19812893 19642983 10737359 18977376 18644402 20101389 19499222 19073162 9163691 19427195 20405173 15885732 21278145 19255062 19426721 20583210 20452335 19996281 20137499 16942905 12112319 20434301 20501860 21167192 19850985 18978307 20118626 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.47 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
19.03 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
19.03 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
19.03 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.03 | 18253720 18079962 18164116 18544905 19004024 17942915 16842330 18093689 17854601 18775883 19126423 16267830 21159647 3124819 18282651 19009564 17174075 19539802 18308698 9362446 19519916 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.03 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.42 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.42 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.42 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
3.91 | 16457693 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D019846 |
Miller Fisher Syndrome |
|
rEV576 protein, tick |
7.90 | 18844789 |
MESH:D020720 |
Myasthenia Gravis, Autoimmune, Experimental |
|
rEV576 protein, tick |
7.90 | 17215252 19194881 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.63 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.63 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 9029167 3581430 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.39 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.21 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.06 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.06 | 16049721 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
5.09 | 16397352 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.44 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.10 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.10 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11222880 11896295 11399792 11118676 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.99 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.99 | 18551238 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.78 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.67 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.67 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.02 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.08 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.08 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.27 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.27 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |